Fundamental Processes Short Notes
One-page CSIR NET revision for Unit 3: replication, repair, recombination, transcription, RNA processing, translation, protein fate and gene regulation.
- 9 min
On this page · 8 sections
The whole of Unit 3 on one page. For explanations and worked problems, go back to the chapter: DNA Replication, Repair and Recombination, Transcription, RNA Processing and Non-coding RNA, Translation, Protein Processing and Degradation and Regulation of Gene Expression and Epigenetics.
Replication
| Fact | Detail |
|---|---|
| Mode | Semi-conservative (Meselson–Stahl 1958): generation 1 one hybrid band; generation n: 2 hybrid of 2ⁿ |
| Polymerase rules | Template + primer 3’-OH; 5’ → 3’ only; leading continuous, lagging in Okazaki fragments |
| Okazaki fragments | 1,000–2,000 nt (bacteria); 100–200 nt (eukaryotes) |
| oriC | DnaA boxes, AT-rich 13-mers, GATC; DnaA-ATP initiator |
| Re-initiation block | SeqA (hemimethylated oriC), RIDA (Hda, DnaA-ATP → ADP) |
| Fork proteins | DnaB helicase (5’ → 3’), DnaC loader, DnaG primase, SSB, gyrase (quinolones on GyrA, novobiocin on GyrB) |
| Pol III | α polymerase; ε 3’ → 5’ exo; β-clamp; γ/τ clamp loader; ~1,000 nt s⁻¹ per fork |
| Pol I | 5’ → 3’ exo removes primers; Klenow lacks it; polA mutants still replicate |
| Ligase | NAD⁺ (E. coli), ATP (eukaryotes, T4) |
| Termination | Ter–Tus fork traps; topo IV decatenates; XerCD at dif |
| Eukaryotic licensing | ORC + Cdc6 + Cdt1 → MCM2–7 in G1; CDK + DDK → CMG (Cdc45–MCM–GINS) in S; geminin |
| Eukaryotic polymerases | α-primase (no proofreading), ε leading, δ lagging, PCNA/RFC, FEN1 + RNase H, ligase I |
| Other polymerases | β (BER), γ (mito), η (TLS past T-T; XP-V), Pol IV/V (SOS) |
| Telomerase | TERT + RNA template; reverse transcriptase; TTAGGG; shelterin |
| Fidelity | Selection 10⁻⁴–10⁻⁵ → proofreading ×100 → MMR ×100–1,000 → 10⁻⁹–10⁻¹⁰ |
| Mutators | mutD (dnaQ), mutS, mutL, mutH, dam |
| Plasmids | ColE1: RNA II primer, RNA I antisense, Rop; pUC lacks rop; rolling circle (φX174, M13, F transfer); incompatibility |
| mtDNA | 16,569 bp (human); Pol γ; D-loop |
Repair and Recombination
| Fact | Detail |
|---|---|
| Direct reversal | Photolyase (light, FADH⁻; absent in placental mammals); MGMT/Ada (suicide, O⁶-meG); AlkB |
| BER | Glycosylase (UNG, OGG1, MUTYH) → APE1 → Pol β (dRP lyase) → ligase III/XRCC1 |
| Why T, not U | Deaminated C (U) is recognisable; 5mC → T makes CpG hotspots |
| NER (E. coli) | UvrA₂B detect, UvrC cuts, 12–13 nt removed, UvrD, Pol I, ligase |
| NER (human) | XPC (global), CSA/CSB (transcription-coupled), TFIIH (XPB, XPD), XPA, XPG (3’), XPF–ERCC1 (5’); ~30 nt |
| MMR | MutS → MutL → MutH nicks unmethylated GATC strand → UvrD + exo → Pol III; MSH2/MLH1, Lynch syndrome |
| DSB repair | HR (MRN, resection, RPA, BRCA2, Rad51; S/G2, accurate) vs NHEJ (Ku70/80, DNA-PKcs, Artemis, ligase IV; error-prone; V(D)J) |
| Checkpoint | ATM → γH2AX (Ser139); ATR at RPA–ssDNA |
| SOS | RecA* → LexA autocleavage; UmuD → UmuD’; Pol V error-prone TLS; also cleaves λ cI |
| HR proteins | RecBCD (Chi 5’-GCTGGTGG-3’), RecA, RuvAB (branch migration), RuvC (resolvase); Rad51, Dmc1, Spo11 |
| Models | Holliday junction; DSBR (double HJ); SDSA (non-crossover) |
| Gene conversion | MMR of heteroduplex → 3:1 (6:2); post-meiotic segregation 5:3 |
| Site-specific | Tyr (Cre, λ Int, FLP, XerCD; HJ intermediate) vs Ser (Hin, resolvases; all strands cut) |
| Site orientation | Direct → excision; inverted → inversion; two molecules → integration |
| loxP | 34 bp = 13 + 8 (spacer) + 13 |
| λ | Integration Int + IHF; excision Int + IHF + Xis |
| Transposition | Cut-and-paste (Tn5, Tn10, Ac/Ds, P); replicative (Tn3, Mu); retrotransposons (Ty1, copia, LINE-1, Alu); target-site duplication |
Transcription and RNA Processing
| Fact | Detail |
|---|---|
| E. coli RNAP | Core α₂ββ’ω + σ |
| σ⁷⁰ promoter | −35 TTGACA, −10 TATAAT, 17 bp spacer; UP element (αCTD) |
| Other σ | σ³² heat shock; σ⁵⁴ (needs ATPase enhancer-binding activator); σˢ stationary; σ²⁸ flagella; σᴱ envelope |
| Termination | Intrinsic: GC hairpin + U-run; Rho: rut site, hexameric ATPase helicase |
| Inhibitors | Rifampicin (β, initiation); streptolydigin (elongation); actinomycin D (DNA, all); α-amanitin (Pol II > III > I); cordycepin; DRB, flavopiridol (CDK9); triptolide (XPB) |
| Pol I / II / III | rRNA (18S, 5.8S, 28S) / mRNA, miRNA, U1, U2, U4, U5 / tRNA, 5S, U6, 7SL |
| GTFs | TFIID (TBP + TAFs) → IIA → IIB → Pol II/IIF → IIE → IIH (XPB, CDK7) |
| CTD | YSPTSPS; Ser5-P (CDK7, capping) → Ser2-P (CDK9/P-TEFb, elongation, 3’ end) |
| Activators | DBD + AD (modular; Gal4 swaps, two-hybrid); Mediator; HATs, remodellers |
| Cap | Triphosphatase, guanylyltransferase, N7-MTase (SAM); m⁷GpppN; CBC then eIF4E |
| Splicing | 5’ GU … branch A … Py … AG 3’; 2 transesterifications; lariat 2’–5’ |
| snRNPs | U1 5’ ss; U2 branch; U4/U6·U5; U6 replaces U1; U2–U6 catalytic; minor U11/U12 |
| Self-splicing | Group I exogenous G, linear; group II branch A, lariat |
| Alternative splicing | SR proteins (enhancers), hnRNPs (silencers); Sxl–Tra–Dsx; Dscam |
| NMD | PTC >50–55 nt upstream of last exon junction; EJC, UPF1 |
| Editing | apoB C→U (APOBEC1) → stop → apoB-48 (intestine); ADAR A→I (GluA2 Q/R); trypanosome U insertion/deletion |
| Poly(A) | AAUAAA (CPSF) 10–30 nt upstream; GU-rich (CstF); PAP; PABPN1; histone mRNAs: stem-loop + SLBP |
| Decay | Deadenylation → decapping → Xrn1; exosome; AU-rich elements |
| rRNA/tRNA | RNase III (bacteria); snoRNAs C/D (2’-O-Me), H/ACA (Ψ); RNase P (ribozyme), CCA addition |
| Export | mRNA NXF1–NXT1 (TREX; Ran-independent); tRNA exportin-t; pre-miRNA exportin-5; CRM1 (NES, HIV Rev–RRE) |
| Ribozymes | Group I/II, RNase P, hammerhead/hairpin/HDV, rRNA peptidyl transferase, spliceosome, glmS; Cech and Altman (Nobel 1989) |
| Riboswitches | Aptamer + expression platform; TPP, FMN, SAM, Lys, Gly, purines; terminator or SD control |
| miRNA | Drosha–DGCR8 → exportin-5 → Dicer → AGO/RISC; seed 2–8; repression + decay |
| siRNA / piRNA | siRNA: perfect pairing, AGO2 slicing; piRNA: Dicer-independent, PIWI, germline transposons |
| lncRNA | Xist, HOTAIR, 7SK, MALAT1, NEAT1 |
| Bacterial ncRNA | sRNAs + Hfq (RyhB, MicF); 6S RNA; tmRNA; crRNA |
Translation and Protein Fate
| Fact | Detail |
|---|---|
| Code | 61 sense + UAA, UAG, UGA; mito UGA = Trp; Sec at UGA + SECIS |
| Wobble | Anticodon 34: G pairs C/U; U pairs A/G; I pairs U/C/A; minimum about 32 tRNAs |
| aaRS | aa-AMP intermediate, 2 ~P; class I 2’-OH (Rossmann), class II 3’-OH; editing site |
| Ribosomes | 70S = 30S (16S) + 50S (23S, 5S); 80S = 40S (18S) + 60S (28S, 5.8S, 5S) |
| Sites | A, P, E; decoding centre 16S; peptidyl transferase = 23S rRNA |
| Bacterial initiation | SD–anti-SD (16S 3’ end); IF1, IF2·GTP, IF3; fMet (N¹⁰-formyl-THF) |
| Eukaryotic initiation | eIF4F (4E, 4G, 4A) on cap; 43S scanning; Kozak: A/G at −3, G at +4; eIF2·GTP·Met-tRNAᵢ; eIF2B GEF; eIF5B; IRES |
| Elongation | EF-Tu (eEF1A) + EF-Ts; rRNA peptide bond; EF-G (eEF2); N → C; ≥4 ~P per bond |
| Termination | RF1 UAA/UAG; RF2 UAA/UGA; RF3; eRF1 all three, eRF3; GGQ; RRF; tmRNA |
| Inhibitors (30S) | Streptomycin (misreading), kanamycin, gentamicin, tetracycline (A site) |
| Inhibitors (50S) | Chloramphenicol (PTC; also mito), erythromycin (tunnel), linezolid; fusidic acid (EF-G), kirromycin (EF-Tu) |
| Inhibitors (all / 80S) | Puromycin (all; A-site analogue); cycloheximide (80S E site); diphtheria toxin (eEF2 ADP-ribosylation); ricin (28S depurination) |
| Translational control | eIF2α-P (HRI, PKR, PERK, GCN2) ⊣ eIF2B → ATF4/GCN4 up; mTORC1 ⊣ 4E-BP; IRE/IRP (ferritin 5’ block; TfR 3’ stabilise); miRNAs; RF2 +1 frameshift |
| N-glycosylation | Asn-X-Ser/Thr; OST in ER; dolichol-PP; tunicamycin; calnexin cycle |
| Lipid anchors | Myristoyl (N-Gly), palmitoyl (Cys, reversible), prenyl (CaaX), GPI |
| Other PTMs | Phosphorylation, acetylation, methylation, disulfide (PDI), hydroxylation (vitamin C), γ-carboxylation (vitamin K), proinsulin → insulin + C-peptide |
| ER entry | Signal → SRP (7SL RNA, SRP54; pauses translation) → SR (GTPases) → Sec61; signal peptidase; stop-transfer, signal-anchor |
| Signals | KDEL (ER), M6P (lysosome; I-cell disease), NLS (PKKKRKV; importin, Ran), NES (CRM1), presequence (TOM/TIM23, Δψ, MPP), SKL (Pex5, folded import), transit peptide (TOC/TIC) |
| Coats | COPII (ER → Golgi, Sar1); COPI (retrograde, ARF1); clathrin (TGN, endocytosis, dynamin); Rab, SNAREs, NSF |
| Bacterial export | Sec (SecA, SecYEG), SRP (Ffh, 4.5S RNA), Tat (folded) |
| UPR | IRE1 (XBP1 splicing), PERK (eIF2α), ATF6 (Golgi cleavage); ERAD |
| Ubiquitin | 76 aa; E1 (ATP) → E2 → E3 (RING, HECT; SCF, APC/C); K48 → proteasome; K63 signalling |
| Proteasome | 26S = 20S (α₇β₇β₇α₇) + 19S; β1 caspase-like, β2 trypsin-like, β5 chymotrypsin-like; N-terminal Thr; bortezomib |
| Degrons | N-end rule (Ubr1), PEST, phosphodegron, D-box, HIF Pro-OH → VHL |
| Autophagy | mTORC1 ⊣ ULK1; LC3-II; p62; CMA: KFERQ, Hsc70, LAMP-2A |
Gene Regulation and Epigenetics
| Fact | Detail |
|---|---|
| lac | LacI tetramer; allolactose (IPTG gratuitous); cAMP–CAP when glucose low; inducer exclusion |
| lac mutants | I⁻ recessive constitutive; Iˢ dominant non-inducible; I⁻ᵈ dominant constitutive; Oᶜ cis-dominant constitutive; P⁻ cis |
| trp | TrpR + Trp; attenuation: 14-aa leader, 2 Trp codons; high Trp → 3–4 terminator; low Trp → 2–3 antiterminator |
| ara | AraC: O₂–I₁ loop represses; arabinose → I₁–I₂ + CAP activates P_BAD |
| Other bacterial | σ cascades (sporulation σᶠ/σᴱ/σᴳ/σᴷ); two-component (His-kinase → Asp); LuxI/LuxR; RelA → (p)ppGpp |
| λ repressor | cI: O_R1 > O_R2 (activates P_RM) > O_R3 |
| λ Cro | O_R3 first → represses P_RM |
| λ decision | CII (FtsH-degraded; CIII protects) → P_RE, P_I, P_aQ → lysogeny; N, Q antiterminators |
| λ mutants | cI⁻/cII⁻/cIII⁻ clear plaques; λ vir (operators); cI857 (heat-inducible); immunity is repressor–operator specific |
| Phages | T7: own single-subunit RNAP; T4: MotA/AsiA, gp55 σ |
| Viruses | HIV Tat–TAR–P-TEFb; Rev–RRE–CRM1; SV40 large T; adenovirus E1A; HSV VP16 |
| Eukaryotic control | Enhancers, silencers, insulators (CTCF), LCR, Mediator, loops/TADs; combinatorial |
| GAL | Gal4 (UAS_G), Gal80 masks AD, galactose–Gal3 sequesters Gal80; glucose represses |
| Nuclear receptors | Steroid receptors + Hsp90 (cytoplasm) → HRE; TR–RXR represses without ligand |
| Nucleosome | 147 bp, octamer (H2A, H2B, H3, H4)₂; H1 |
| Remodellers | SWI/SNF, ISWI, CHD, INO80/SWR1 (H2A.Z) |
| Active marks | H3K4me3 (promoter), H3K36me3 (body), H3K27ac, H3K4me1 (enhancers), H4K16ac |
| Silent marks | H3K9me3 (SUV39H1 → HP1), H3K27me3 (PRC2/EZH2 → PRC1, H2AK119ub1) |
| Erasers | HDACs (TSA, butyrate); sirtuins (NAD⁺); LSD1 (FAD); JmjC (Fe²⁺, α-KG) |
| Variants | H2A.Z, H3.3, CENP-A, macroH2A, γH2AX |
| DNA methylation | CpG; DNMT1 + UHRF1 maintenance; DNMT3A/B de novo; MeCP2/MBD; TET → 5hmC → 5fC → 5caC |
| Assays | Bisulfite: unmethylated C → T; 5mC stays C; HpaII blocked by CmCGG, MspI not |
| Silencing | Sir2/3/4 (budding yeast HM loci, telomeres); RITS–Clr4–Swi6 (fission yeast); PEV (Su(var)); RdDM (plants); piRNA |
| Dosage compensation | Mammals: Xist (Tsix), random X-inactivation (imprinted in marsupials, mouse extra-embryonic); fly: male X ×2 (MSL, H4K16ac); worm: XX ÷2 |
| Imprinting | Igf2/H19: maternal ICR unmethylated + CTCF → H19; paternal methylated → Igf2 |
| Disorders | Prader–Willi (paternal 15q11–q13 loss); Angelman (maternal UBE3A loss) |
Classic Experiments (Part C favourites)
| Experiment | Showed |
|---|---|
| Meselson–Stahl (¹⁵N/¹⁴N, CsCl) | Semi-conservative replication |
| Okazaki pulse-labelling | Discontinuous lagging-strand synthesis |
| polA mutant viability | Pol I is not the main replicase |
| Cys-tRNA → Ala-tRNACys | Ribosome reads the tRNA, not the amino acid |
| α-Amanitin titration of nuclei | Three distinct nuclear RNA polymerases |
| Tetrahymena intron, RNase P | RNA can catalyse (ribozymes) |
| Puromycin reaction | P-site peptidyl-tRNA; translocation |
| Signal-sequence fusions and SRP | Signal hypothesis |
| lac merodiploids (Jacob and Monod) | Operator cis, repressor trans |
| trp leader mutations (Yanofsky) | Attenuation via coupled translation |
| λ clear-plaque and vir mutants | Repressor–operator control of lysogeny |
| Fire and Mello (dsRNA in C. elegans) | RNA interference |
| HpaII/MspI and bisulfite | CpG methylation mapping |
Ten-Second Formula Card
$$\text{hybrid fraction after } n \text{ generations} = \frac{2}{2^n}\ (n \ge 1) \qquad t_{\text{replication}} = \frac{\text{genome length}/2}{\text{fork speed}}$$$$\text{origins}_{\min} = \frac{\text{chromosome length}}{2 \times \text{fork speed} \times t_S} \qquad \text{errors per replication} = N \times \varepsilon_{\text{insert}} \times f_{\text{proofread}} \times f_{\text{MMR}}$$$$\text{high-energy bonds per peptide bond} \ge 4 \qquad \text{ribosomes per mRNA} = \frac{\text{time to translate}}{\text{initiation interval}} \qquad t_{1/2} = \frac{0.693}{k}$$What’s Next
- Go back to the chapter overview and redo the Level 3 questions on each page without looking at the solutions.
- Structure and Function of Biomolecules — Quick Revision — the biochemistry this unit builds on.
- Life Sciences & Biotechnology — the full 14-unit syllabus.